Evidence map›Paper›PMID 28636952›Full record

ArticleImmunity2017

Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Charles L Dulberger, Curtis P McMurtrey, Angelique Hölzemer, Karlynn E Neu, Victor Liu, Adriana M Steinbach, Wilfredo F Garcia-Beltran, Michael Sulak, Bana Jabri, Vincent J Lynch and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Impact ofFrontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Integrative omics and multi-cohort identifyJournal of biomedical research · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Charles L DulbergerDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.
Curtis P McMurtreyDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Angelique HölzemerHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg 20251, Germany; First Department of Internal Medicine, Infectious Disease Unit, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; German Center for Infection Research (DZIF), Hamburg 20246, Germany.
Karlynn E NeuCommittee on Immunology, University of Chicago, Chicago, IL 60637, USA.
Victor LiuDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.
Adriana M SteinbachDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.
Wilfredo F Garcia-BeltranRagon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
Michael SulakDepartment of Human Genetics, The University of Chicago, Chicago, IL 60637, USA.
Bana JabriCommittee on Immunology, The University of Chicago, Chicago, IL 60637, USA; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Vincent J LynchDepartment of Human Genetics, The University of Chicago, Chicago, IL 60637, USA.
Marcus AltfeldHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg 20251, Germany.
William H HildebrandDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Erin J AdamsDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA. Electronic address: ejadams@uchicago.edu.
University of Chicago · USLeibniz Institute of Virology (LIV) · DEUniversity of Oklahoma Health Sciences Center · USRagon Institute of MGH, MIT and Harvard · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Molecular Recognition of Ligand by the Gamma Delta T Cell ReceptorR01AI073922 · NIAID · UNIVERSITY OF CHICAGO · PI ADAMS, ERIN JUNE · 2007 to 2016
$3.8M
Gamma Delta T cell surveillance of metabolites as signals of cellular stressR01AI115471 · NIAID · UNIVERSITY OF CHICAGO · PI ADAMS, ERIN JUNE · 2015 to 2019
$1.9M
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progressionF31AI116366 · NIAID · HARVARD MEDICAL SCHOOL · PI GARCIA-BELTRAN, WILFREDO F · 2015 to 2018
$157k
NIAID NIH HHS F31 AI116366NIAID NIH HHS R01 AI073922NIAID NIH HHS R01 AI115471NIGMS NIH HHS T32 GM007183NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Evidence is mounting that the major histocompatibility complex (MHC) molecule HLA-F (human leukocyte antigen F) regulates the immune system in pregnancy, infection, and autoimmunity by signaling through NK cell receptors (NKRs). We present structural, biochemical, and evolutionary analyses demonstrating that HLA-F presents peptides of unconventional length dictated by a newly arisen mutation (R62W) that has produced an open-ended groove accommodating particularly long peptides. Compared to empty HLA-F open conformers (OCs), HLA-F tetramers bound with human-derived peptides differentially stained leukocytes, suggesting peptide-dependent engagement. Our in vitro studies confirm that NKRs differentiate between peptide-bound and peptide-free HLA-F. The complex structure of peptide-loaded β

Indexed as

Molecular MimicryAntigen PresentationAntigensAntigens, CDBiological EvolutionCrystallography, X-RayFemaleHEK293 CellsHistocompatibility Antigens Class IHumansKiller Cells, NaturalLeukocyte Immunoglobulin-like Receptor B1MutationPeptide FragmentsPregnancyProtein BindingAntigensAntigens, CDHistocompatibility Antigens Class IHLA-F antigensLeukocyte Immunoglobulin-like Receptor B1LILRB1 protein, humanPeptide FragmentsReceptors, ImmunologicReceptors, Natural Killer CellViral ProteinsHLA-F structureKIRLIRMHC antigen presentationMHC-I evolutionNK cell receptorNK cell regulation

Identifiers

PMID28636952
PMCPMC5523829
OpenAlexW2640667059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.